Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS vs CIPLA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NEULAND LABS CIPLA NEULAND LABS/
CIPLA
 
P/E (TTM) x 25.1 31.2 80.4% View Chart
P/BV x 8.0 5.0 159.9% View Chart
Dividend Yield % 0.2 0.6 27.5%  

Financials

 NEULAND LABS   CIPLA
EQUITY SHARE DATA
    NEULAND LABS
Mar-23
CIPLA
Mar-23
NEULAND LABS/
CIPLA
5-Yr Chart
Click to enlarge
High Rs2,0041,185 169.1%   
Low Rs966852 113.4%   
Sales per share (Unadj.) Rs928.4281.9 329.4%  
Earnings per share (Unadj.) Rs127.435.1 362.8%  
Cash flow per share (Unadj.) Rs168.649.7 339.5%  
Dividends per share (Unadj.) Rs10.008.50 117.6%  
Avg Dividend yield %0.70.8 80.7%  
Book value per share (Unadj.) Rs774.8289.2 267.9%  
Shares outstanding (eoy) m12.83807.15 1.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.63.6 44.3%   
Avg P/E ratio x11.729.0 40.2%  
P/CF ratio (eoy) x8.820.5 42.9%  
Price / Book Value ratio x1.93.5 54.4%  
Dividend payout %7.824.2 32.4%   
Avg Mkt Cap Rs m19,052822,164 2.3%   
No. of employees `000NANA-   
Total wages/salary Rs m2,01838,301 5.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m11,912227,531 5.2%  
Other income Rs m975,121 1.9%   
Total revenues Rs m12,009232,653 5.2%   
Gross profit Rs m2,71848,079 5.7%  
Depreciation Rs m52811,721 4.5%   
Interest Rs m1311,095 11.9%   
Profit before tax Rs m2,15740,384 5.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m52212,029 4.3%   
Profit after tax Rs m1,63528,355 5.8%  
Gross profit margin %22.821.1 108.0%  
Effective tax rate %24.229.8 81.3%   
Net profit margin %13.712.5 110.2%  
BALANCE SHEET DATA
Current assets Rs m7,609168,051 4.5%   
Current liabilities Rs m4,39050,333 8.7%   
Net working cap to sales %27.051.7 52.2%  
Current ratio x1.73.3 51.9%  
Inventory Days Days673 8.7%  
Debtors Days Days1,1097 17,032.6%  
Net fixed assets Rs m8,189117,318 7.0%   
Share capital Rs m1291,614 8.0%   
"Free" reserves Rs m9,812231,845 4.2%   
Net worth Rs m9,941233,460 4.3%   
Long term debt Rs m7420-   
Total assets Rs m15,798290,067 5.4%  
Interest coverage x17.537.9 46.2%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.80.8 96.1%   
Return on assets %11.210.2 110.1%  
Return on equity %16.412.1 135.4%  
Return on capital %21.417.8 120.5%  
Exports to sales %73.522.6 324.4%   
Imports to sales %15.18.9 170.6%   
Exports (fob) Rs m8,75051,516 17.0%   
Imports (cif) Rs m1,80420,202 8.9%   
Fx inflow Rs m8,75064,282 13.6%   
Fx outflow Rs m1,80420,202 8.9%   
Net fx Rs m6,94644,080 15.8%   
CASH FLOW
From Operations Rs m2,37232,377 7.3%  
From Investments Rs m-615-23,885 2.6%  
From Financial Activity Rs m-1,358-9,583 14.2%  
Net Cashflow Rs m403-968 -41.7%  

Share Holding

Indian Promoters % 32.8 13.4 244.2%  
Foreign collaborators % 0.0 20.0 -  
Indian inst/Mut Fund % 29.1 50.0 58.3%  
FIIs % 22.7 25.7 88.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 67.2 66.5 101.0%  
Shareholders   27,723 425,731 6.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NEULAND LABS With:   DIVIS LABORATORIES    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    SUPRIYA LIFESCIENCE     


More on NEULAND LABS vs Cipla

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

NEULAND LABS vs Cipla Share Price Performance

Period NEULAND LABS Cipla S&P BSE HEALTHCARE
1-Day -1.17% -2.81% -1.15%
1-Month -12.29% -1.69% -5.20%
1-Year 280.25% 66.68% 57.17%
3-Year CAGR 46.59% 23.87% 18.07%
5-Year CAGR 54.97% 22.08% 18.83%

* Compound Annual Growth Rate

Here are more details on the NEULAND LABS share price and the Cipla share price.

Moving on to shareholding structures...

The promoters of NEULAND LABS hold a 32.8% stake in the company. In case of Cipla the stake stands at 33.5%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of NEULAND LABS and the shareholding pattern of Cipla.

Finally, a word on dividends...

In the most recent financial year, NEULAND LABS paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 7.8%.

Cipla paid Rs 8.5, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of NEULAND LABS, and the dividend history of Cipla.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3% Sensex Today Trades Lower | Metal & PSB Stocks Shine | TCS, Apollo Tyre Drop 3%(10:30 am)

Asian shares slipped before a Bank of Japan policy decision where authorities are likely to bring an end to the world's last negative rates regime.